Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment


A new study from the University of Hong Kong demonstrates the combination of lopinavir/ ritonavir, ribavirin and interferon beta-1b shortens the recovery time from COVID-19 and reduces the viral load.  

Content Information

Content Author: 
The University of Hong Kong
Content Source: 
US National Institutes of Health
Content Type: 
News